
Human TNFSF11/RANKL PicoKine ELISA Kit standard curve
Human TNFSF11/RANKL ELISA Kit PicoKine(r)
EK0842
Product group Assays
Overview
- SupplierBoster Bio
- Product NameHuman TNFSF11/RANKL PicoKine ELISA Kit
- Delivery Days Customer9
- ApplicationsELISA
- Applications SupplierELI
- Assay Detection Range78 pg/ml - 5,000 pg/ml
- Assay Sensitivity<10 pg/ml
- Assay Time15-20
- CertificationResearch Use Only
- Scientific DescriptionHuman TNFSF11/RANKL ELISA Kit PicoKine® (96 Tests). Quantitate Human TNFSF11 in cell culture supernatants, cell lysates, serum and plasma (heparin, EDTA). Sensitivity: 10 pg/ml. The brand Picokine indicates this is a premium quality ELISA kit. Each Picokine kit delivers precise quantification, high sensitivity, and excellent reproducibility. Only our most reliable and effective kits qualify as Picokine, guaranteeing top-tier results for your assays.
- Reactivity SupplierHuman TNFSF11
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC41116158
References
- Elshamy AM, Hafez YM, Safa MAE, et al. The role of miR-433-3p in vascular calcification in type 2 diabetic patients: targeting WNT/β-Catenin and RANKL/RANK/OPG signaling pathways. Mol Biol Rep. 2023,50(11):9073-9083. doi: 10.1007/s11033-023-08792-9Read this paper
- Li Y, Yang S. Rb1 negatively regulates bone formation and remodeling through inhibiting transcriptional regulation of YAP in Glut1 and OPG expression and glucose metabolism in male mice. Mol Metab. 2022,66:101630. doi: 10.1016/j.molmet.2022.101630Read this paper
- Hussein R, Aboukhamis I. The association of serum RANKL levels with disease activity and hematological parameters in Syrian patients with rheumatoid arthritis. Biochem Biophys Rep. 2022,32:101373. doi: 10.1016/j.bbrep.2022.101373Read this paper
- Bakkalci D, Jay A, Rezaei A, et al. Bioengineering the ameloblastoma tumour to study its effect on bone nodule formation. Sci Rep. 2021,11(1):24088. doi: 10.1038/s41598-021-03484-5Read this paper
- Colombo MV, Bersini S, Arrigoni C, et al. Engineering the early bone metastatic niche through human vascularized immuno bone minitissues. Biofabrication. 2021,13(3). doi: 10.1088/1758-5090/abefeaRead this paper
- Wang J, Tie N, Li H, et al. Inhibitory Effect of Tetramerized Single-Chain Variable Fragment of Anti-Cyclic Citrullinated Peptide Antibodies on the Proliferation, Activation, and Secretion of Cytokines of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis In Vitro Co-Culture System. Inflammation. 2020,43(6):2245-2255. doi: 10.1007/s10753-020-01292-zRead this paper
- Karalazou P, Ntelios D, Chatzopoulou F, et al. OPG/RANK/RANKL signaling axis in patients with type I diabetes: Associations with parathormone and vitamin D. Ital J Pediatr. 2019,45(1):161. doi: 10.1186/s13052-019-0748-1Read this paper
- Liang C, Li J, Lu C, et al. HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis. Nat Commun. 2019,10(1):4579. doi: 10.1038/s41467-019-12163-zRead this paper
- Giannasi C, Niada S, Farronato D, et al. Nitrogen Containing Bisphosphonates Impair the Release of Bone Homeostasis Mediators and Matrix Production by Human Primary Pre-Osteoblasts. Int J Med Sci. 2019,16(1):23-32. doi: 10.7150/ijms.27470Read this paper
- Liu S, Luo ZH, Ji GM, et al. Cajanolactone A from Cajanus cajan Promoted Osteoblast Differentiation in Human Bone Marrow Mesenchymal Stem Cells via Stimulating Wnt/LRP5/β-Catenin Signaling. Molecules. 2019,24(2). doi: 10.3390/molecules24020271Read this paper